Product image of Ketesse (Dexketoprofen) supplied by GNH India

Ketesse

Active Ingredient:
Dexketoprofen
Origin:
EU

Ketesse (Dexketoprofen)

Dexketoprofen, the active ingredient in Ketesse, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It provides analgesic and anti‑inflammatory effects for the relief of pain and inflammation in adult patients.

GNH India supplies Ketesse as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from consistent batch release, regulatory support, and responsive technical service.

Manufacturer / TM Owner

Menarini International Operations Luxembourg S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Dexketoprofen, an NSAID, reduces pain and inflammation by inhibiting cyclooxygenase enzymes.

  • Acute musculoskeletal pain: provides rapid relief of pain and swelling associated with sprains, strains, and backache.
  • Dental pain: alleviates postoperative discomfort and inflammatory pain after dental procedures.
  • Post‑operative pain: manages moderate pain following minor surgical interventions.

How It Works

  • Dexketoprofen exerts its effect by reversibly inhibiting cyclooxygenase‑1 (COX‑1) and cyclooxygenase‑2 (COX‑2) enzymes, which blocks the conversion of arachidonic acid to prostaglandins. The reduction in prostaglandin synthesis diminishes peripheral sensitisation of nociceptors and decreases inflammatory exudate, resulting in analgesia and anti‑inflammatory activity. By limiting prostaglandin‑mediated vasodilation and capillary permeability, dexketoprofen also contributes to reduced edema and erythema at the site of injury.

Side Effects

Dexketoprofen may cause a range of adverse reactions, which are classified by frequency and severity.

Common Side Effects

  • Gastrointestinal discomfort: mild nausea, dyspepsia, or abdominal pain.
  • Headache: transient headache occurring shortly after dosing.
  • Dizziness: light‑headed sensation without loss of balance.

Serious or Rare Side Effects

  • Gastrointestinal ulcer or bleeding: severe hemorrhage or perforation of the stomach or intestines.
  • Severe hypersensitivity: anaphylaxis, angioedema, or bronchospasm.
  • Renal impairment: acute kidney injury or worsening of chronic renal disease.

Precautions & Warnings

When prescribing dexketoprofen, clinicians should consider several precautionary measures to minimise risk.

  • Assess gastrointestinal risk: evaluate history of ulcers, bleeding, or chronic NSAID use.
  • Evaluate renal function: monitor creatinine and avoid use in severe renal impairment.
  • Monitor cardiovascular status: use caution in patients with hypertension or thrombotic disease.
  • Use lowest effective dose: prescribe the minimal dose for the shortest duration needed.
  • Avoid in known hypersensitivity: discontinue if allergic reactions occur.
  • Store at ambient temperature: keep tablets in the original container, protect from moisture and heat.

Avoid Interactions

Dexketoprofen can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

  • Anticoagulants (e.g., warfarin): increased risk of bleeding.
  • Other NSAIDs or aspirin: additive gastrointestinal toxicity.
  • ACE inhibitors (e.g., enalapril): may reduce renal function.

Moderate Interactions (Monitor Closely)

  • Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency.
  • Diuretics (e.g., furosemide): possible reduction in renal clearance.

Frequently Asked Questions

Ketesse contains dexketoprofen, an NSAID indicated for the short‑term relief of moderate pain and inflammation. It is commonly prescribed for acute musculoskeletal pain, dental pain after procedures, and post‑operative discomfort following minor surgeries.

Dexketoprofen works by reversibly blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which reduces the synthesis of prostaglandins. Lower prostaglandin levels decrease peripheral sensitisation of pain receptors and limit the inflammatory response, providing analgesic and anti‑inflammatory effects.

The appropriate dose of Ketesse is determined by the prescribing healthcare professional based on the patient’s condition, age, renal and hepatic function, and other individual factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of dexketoprofen in pregnancy and lactation has not been fully established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and only under medical supervision.

To request Ketesse, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ketesse (dexketoprofen) is a potent NSAID with a rapid onset of action, often comparable to ibuprofen or naproxen but requiring lower doses for similar analgesic effect. Its short half‑life may reduce the risk of accumulation, yet it shares the same class‑related gastrointestinal and cardiovascular cautions.

Ketesse tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect them from moisture and heat. Keep the product out of reach of children and avoid exposing it to direct sunlight.

Ketesse is taken orally with a glass of water. It may be taken with or without food, although taking it with food can lessen mild gastrointestinal discomfort. The tablet should be swallowed whole and not crushed or chewed unless directed by a healthcare professional.

The most serious adverse events include gastrointestinal ulceration or bleeding, severe hypersensitivity reactions such as anaphylaxis, renal impairment, and cardiovascular events like myocardial infarction or stroke. Patients should be monitored for these signs, especially if they have pre‑existing risk factors.

Ketesse should be avoided in individuals with known hypersensitivity to dexketoprofen or other NSAIDs, active gastrointestinal ulcer or bleeding, severe renal or hepatic impairment, and in patients with established cardiovascular disease where NSAIDs are contraindicated. Consultation with a physician is essential before starting therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.